Navigation Links
ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
Date:4/30/2008

006, ISTA licensed from Senju the exclusive North American rights to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. Without limiting the foregoing, but by way of example, statements contained in this press release related to bringing a new product to market every 12 to 18 months, completing the preliminary analysis of the data from the Bepreve ocular safety study in the second quarter of 2008, filing the Bepreve NDA with the FDA in the second half of 2008, and becoming the leading niche ophthalmic pharmaceutical company are forward-looking statements. Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements. These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ from current expectations include, among others: timely and successful implementat
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
2. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
3. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
4. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
5. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
6. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
9. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DES MOINES, Iowa , Jan. 23, 2015  The Partnership to ... Iowa health care leaders and a new study ... prescription medications. The PFCD is a nationwide coalition working to educate ... The research released at the Capitol was focused on how the ...
(Date:1/23/2015)... and DUBLIN , Jan. 23, 2015 ... with KRS Global Biotechnology, Inc. for the compounding, packaging and ... for shipment in the United States . ... Outsourcing Facility capable of compounding naltrexone tablets in various strengths ...
(Date:1/23/2015)...  iMD Companies, Inc. (ICBU) has repositioned itself as a holding ... a foothold in the hydroponic, hemp and medical marijuana sectors. ... in the sector, and recently partnering with the Chippewa Tribe ... medical marijuana, iMD is committing to bring its vision to ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... LOUIS, March 1, 2011 K-V Pharmaceutical Company (NYSE: KVa/KVb) ... million of senior secured notes due 2015 (the "Notes") in ... The Notes will be offered only to accredited investors pursuant ... amended (the "Securities Act").  The Notes have not been registered ...
... Medical Systems Ltd. (Nasdaq: DHRM ) ... the development, assembly, marketing and sale of medical ... announced that management will present at the following ... http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO ) Rodman & Renshaw ...
Cached Medicine Technology:K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 2K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 3K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 4K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 5K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 6K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 7K-V Pharmaceutical Company Announces $200 Million Private Debt Offering 8Dehaier Medical Announces March Investor Presentations 2
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... EAGAN, Minn. (PRWEB) January 22, 2015 Blue ... discover those Minnesotans who exemplify what it means to “Live ... a chance for people to share their stories about how ... adversity or simply inspired others by living in the moment. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... 2015 Autocarinsurancebest.com has released a new blog ... auto insurance policy . , Auto insurance quotes help ... is no longer necessary to call an agent or visit ... online on a single website: http://autocarinsurancebest.com/ . , Every ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... Risperidone, a drug used to control schizophrenia symptoms, ... spectrum disorder, according to a new review of ... randomized, placebo-controlled studies of risperidone (Risperdal) involving 211 ... found] that risperidone may be beneficial for various ...
... common man. They are intended to boost the sale of any ... comes to promoting// drugs through commercials, the campaigns are so credible ... them. ,This was revealed in a survey conducted by ... California – Los Angeles Department of Medicine. This group has arrived ...
... New Delhi: India's leading IT firm Tata Consultancy Services ... Singapore-based //Parkway Hospitals to provide and implement a healthcare ... TCS will work with Parkway Hospitals to customize and ... specific needs, a TCS release said. ,Parkway Hospitals ...
... filing a petition against a court ruling that seeks to stop ... makes this news significant is that its outcome will determine the ... manageable crisis. , Novartis is backing its right to patent ... to treat leukemia. If it wins its case this will mean ...
... Skin cancer amongst sunbed users has gone up three times ... Nearly 100 patients are dying annually due to cancer caused ... that nearly 83% of sun beds have UV light outputs ... European standard. Further, there has been a 30% increase in ...
... puffy nose, during winter is extremely common. Most people are ... Experts advice certain protective tips which could// help reduce the ... cold and flu viruses are transmitted after contact with an ... over. In the context, they advice, that it is ...
Cached Medicine News:Health News:Antipsychotic Drug Controls Some Symptoms in Autism Disorder 2Health News:To Patent or Not-A Question of Life 2
... size AA required). Fast, Lightweight Strain Gage ... GN, dwt, mom, dwt, tael), Specific Gravity ... Auto Print. Optional hook (321-34532-03) available for ... ordered for AC Operation of ELB. External ...
... size AA required). Fast, Lightweight Strain Gage ... GN, dwt, mom, dwt, tael), Specific Gravity ... Auto Print. Optional hook (321-34532-03) available for ... ordered for AC Operation of ELB. External ...
... TOPLOAD 620/0.01G, BX620S. Digital stability control, ... measure, piece counting and percent measure ... including date and time data from ... external weights (selectable from 200g to ...
Guaranteed leak-proof , Teflon coating is impervious to corrosive materials , Shock-resistant , NBS tolerances of accuracy , Thermometers are 225 mm long with an immersion length of 35 mm ...
Medicine Products: